Vizsgálati helyszín
Natalie Warren Bryant Cancer Center at Saint Francis
Tulsa, Oklahoma 74136, Egyesült ÁllamokMég nincs intézményhez kötve
- 2futó vizsgálat
- 16lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 18 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis14 vizsgálat
- 2. fázis1 vizsgálat
- Állapot
- Lezárult16 vizsgálat
- Fut, nem toboroz1 vizsgálat
- Toboroz1 vizsgálat
- Fő szponzor
- National Cancer Institute (NCI)8 vizsgálat
- Children's Oncology Group7 vizsgálat
- Alliance for Clinical Trials in Oncology1 vizsgálat
- Radiation Therapy Oncology Group1 vizsgálat
- SWOG Cancer Research Network1 vizsgálat
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
NCT01708941· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
NCT01546987· 3. fázis· Radiation Therapy Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
NCT01120249· 3. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
NCT01231906· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT01190930· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
NCT00632853· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Lezárult
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
NCT00379340· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
NCT00352534· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Forrás
Lezárult
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241· Children's Oncology Group· Forrás
Hibát jelzek